LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, ...

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced its partnership with Will ...

STAAR Surgical Company, a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, has received approval from the Medical Devices Bureau of Health ...

“EVO ICL is the next logical step in refractive innovation. While adoption of any new technology takes time, EVO ICL’s adoption rate has been steadily rising since launch – achieving market leadership ...

Agreement is Largest Commitment to EVO ICL™ in the U.S. Tom Frinzi, Chair of the Board, President and CEO, STAAR Surgical (Left) and Dr. Robert T. Lin, founder and surgeon, IQ Laser Vision (Right).

Please provide your email address to receive an email when new articles are posted on . The STAAR EVO ICL, which is approved for correction of 3 D to 20 D of myopia and 1 D to 4 D of astigmatism, ...

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICLTM) for myopia, astigmatism and presbyopia, is proud to ...

STAAR Surgical (STAA) is a leader in refractive surgery using Implantable Collamer Lenses, offering solutions for moderate to high myopes Acquisition of STAAR is complementary to Alcon’s laser vision ...

WASHINGTON - The FDA has approved a surgically implantable lens designed to treat nearsightedness, giving myopic adults another alternative to eyeglasses or Lasik surgery, Staar Surgical Co. said ...

For more than 35 years, Doug Hattery has worn glasses every waking moment of the day. All that changed last month, when he was one of the first in the Quad-Cities to get a new implantable lens to ...